Highlights from the Ratings and Financial Report for Inovio Pharmaceuticals Inc. (INO) – News Heater

Highlights from the Ratings and Financial Report for Inovio Pharmaceuticals Inc. (INO)

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Inovio Pharmaceuticals Inc. (NASDAQ:INO) went up by 9.38% from its latest closing price compared to the recent 1-year high of $33.79. The company’s stock price has collected 10.79% of gains in the last five trading sessions. MarketWatch.com reported on 02/12/21 that Inovio Pharmaceuticals Inc. stock rises Friday, outperforms market

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Is It Worth Investing in Inovio Pharmaceuticals Inc. (NASDAQ :INO) Right Now?

Plus, the 36-month beta value for INO is at 0.97. Opinions of the stock are interesting as 3 analysts out of 9 who provided ratings for Inovio Pharmaceuticals Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 5 rated it as “hold,” and 1 as “sell.”

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!


The average price from analysts is $15.13, which is $0.91 above the current price. INO currently public float of 166.65M and currently shorts hold a 25.99% ratio of that float. Today, the average trading volume of INO was 15.60M shares.

INO’s Market Performance

INO stocks went up by 10.79% for the week, with a monthly jump of 54.15% and a quarterly performance of 32.65%, while its annual performance rate touched 268.39%. The volatility ratio for the week stands at 9.69% while the volatility levels for the past 30 days are set at 13.94% for Inovio Pharmaceuticals Inc.. The simple moving average for the period of the last 20 days is 18.94% for INO stocks with a simple moving average of 1.60% for the last 200 days.

Analysts’ Opinion of INO

Many brokerage firms have already submitted their reports for INO stocks, with Oppenheimer repeating the rating for INO by listing it as a “Outperform.” The predicted price for INO in the upcoming period, according to Oppenheimer is $35 based on the research report published on February 12th of the current year 2021.

ROTH Capital gave a rating of “Neutral” to INO, setting the target price at $8 in the report published on November 10th of the previous year.

INO Trading at 29.08% from the 50-Day Moving Average

After a stumble in the market that brought INO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -57.92% of loss for the given period.

Volatility was left at 13.94%, however, over the last 30 days, the volatility rate increased by 9.69%, as shares surge +51.76% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +14.49% upper at present.

During the last 5 trading sessions, INO rose by +10.79%, which changed the moving average for the period of 200-days by +3.49% in comparison to the 20-day moving average, which settled at $12.20. In addition, Inovio Pharmaceuticals Inc. saw 60.68% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at INO starting from Kim Jong Joseph, who sale 62,500 shares at the price of $14.24 back on Feb 03. After this action, Kim Jong Joseph now owns 1,078,313 shares of Inovio Pharmaceuticals Inc., valued at $890,000 using the latest closing price.

Kim Jong Joseph, the Chief Executive Officer of Inovio Pharmaceuticals Inc., sale 100,000 shares at $15.00 during a trade that took place back on Feb 01, which means that Kim Jong Joseph is holding 1,078,313 shares at $1,500,000 based on the most recent closing price.

Stock Fundamentals for INO

Current profitability levels for the company are sitting at:

  • -2855.31 for the present operating margin

The net margin for Inovio Pharmaceuticals Inc. stands at -2902.75. The total capital return value is set at -122.34, while invested capital returns managed to touch -127.11. Equity return is now at value -103.00, with -52.70 for asset returns.

Based on Inovio Pharmaceuticals Inc. (INO), the company’s capital structure generated 2,896.79 points at debt to equity in total, while total debt to capital is 96.66. Total debt to assets is 65.46, with long-term debt to equity ratio resting at 2,836.39. Finally, the long-term debt to capital ratio is 94.65.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

When we switch over and look at the enterprise to sales, we see a ratio of 82.13, with the company’s debt to enterprise value settled at 0.29. The receivables turnover for the company is 1.35 and the total asset turnover is 0.03. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.94.

Sign up for our FREE Newsletter and get:

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Important Earnings

Insider Watchlist

We do not sell or share your information with anyone.